SHE:002262 Revenue

Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.50B CNY in the quarter ending June 30, 2025, with 6.64% growth. This brings the company's revenue in the last twelve months to 5.94B, up 9.99% year-over-year. In the year 2024, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.70B with 13.01% growth.

Revenue (ttm)

5.94B

Revenue Growth

+9.99%

P/S Ratio

4.02

Revenue / Employee

1.00M

Employees

5,923

Market Cap

23.90B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.70B	656.13M	13.01%
Dec 31, 2023	5.04B	742.99M	17.28%
Jan 1, 2023	4.30B	362.85M	9.22%
Jan 1, 2022	3.94B	574.36M	17.09%
Dec 31, 2020	3.36B	-788.01M	-18.99%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	41.48B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings